Drug Profile
Indium quinoline complex
Latest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer BTG; Nonindustrial source
- Class Antibacterials; Heavy metals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 02 Jun 1995 New profile
- 02 Jun 1995 Discontinued-Preclinical for Bacterial infections in United Kingdom (Unknown route)